397 related articles for article (PubMed ID: 28811903)
1. Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients.
Yu Y; Qian L; Cui J
Mol Clin Oncol; 2017 Sep; 7(3):498-506. PubMed ID: 28811903
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients.
Zhao QT; Yang Y; Xu S; Zhang XP; Wang HE; Zhang H; Wang ZK; Yuan Z; Duan GC
Onco Targets Ther; 2015; 8():2731-8. PubMed ID: 26491346
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
5. Association of the neutrophil to lymphocyte ratio and clinical outcomes in patients with lung cancer receiving immunotherapy: a meta-analysis.
Jin J; Yang L; Liu D; Li W
BMJ Open; 2020 Jun; 10(6):e035031. PubMed ID: 32499266
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs).
Li Y; Zhang Z; Hu Y; Yan X; Song Q; Wang G; Chen R; Jiao S; Wang J
Front Oncol; 2020; 10():654. PubMed ID: 32656072
[No Abstract] [Full Text] [Related]
7. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Chen X; Meng F; Jiang R
Front Oncol; 2021; 11():746976. PubMed ID: 34900692
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis.
Wang Z; Zhan P; Lv Y; Shen K; Wei Y; Liu H; Song Y
Transl Lung Cancer Res; 2019 Jun; 8(3):214-226. PubMed ID: 31367535
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of neutrophil-to- lymphocyte ratio in esophageal cancer: a meta-analysis.
Yang X; Huang Y; Feng JF; Liu JS
Onco Targets Ther; 2015; 8():789-94. PubMed ID: 25914549
[TBL] [Abstract][Full Text] [Related]
11. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.
Peng H; Luo X
Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of neutrophil-to-lymphocyte ratio for nasopharyngeal carcinoma: A meta-analysis.
Yin J; Qin Y; Luo YK; Feng M; Lang JY
Medicine (Baltimore); 2017 Jul; 96(29):e7577. PubMed ID: 28723793
[TBL] [Abstract][Full Text] [Related]
14. A reliable and feasible way to predict the benefits of Nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies.
Cao D; Xu H; Xu X; Guo T; Ge W
Oncoimmunology; 2018; 7(11):e1507262. PubMed ID: 30377569
[No Abstract] [Full Text] [Related]
15. Prognostic and Clinicopathologic Significance of Neutrophil-to-Lymphocyte Ratio in Esophageal Cancer: An Update Meta-Analysis.
Li B; Xiong F; Yi S; Wang S
Technol Cancer Res Treat; 2022; 21():15330338211070140. PubMed ID: 35025614
[No Abstract] [Full Text] [Related]
16. Neutrophil-lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis.
Wang Z; Peng S; Xie H; Guo L; Jiang N; Shang Z; Niu Y
Cancer Manag Res; 2018; 10():3599-3610. PubMed ID: 30271208
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.
Gu XB; Tian T; Tian XJ; Zhang XJ
Sci Rep; 2015 Jul; 5():12493. PubMed ID: 26205001
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis.
Lu Y; Jiang J; Ren C
PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis.
Zhan H; Ma JY; Jian QC
Clin Chim Acta; 2018 Sep; 484():136-140. PubMed ID: 29856976
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis.
Li X; Ma X; Tang L; Wang B; Chen L; Zhang F; Zhang X
Oncotarget; 2017 Sep; 8(37):62681-62692. PubMed ID: 28977980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
